BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 9351970)

  • 21. BCR-ABL does not prevent apoptotic death induced by human natural killer or lymphokine-activated killer cells.
    Roger R; Issaad C; Pallardy M; Léglise MC; Turhan AG; Bertoglio J; Bréard J
    Blood; 1996 Feb; 87(3):1113-22. PubMed ID: 8562937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antisense oligodeoxynucleotide of telomerase gene enhances cisplatin-induced apoptosis in acute myeloid leukemia and chronic myeloid leukemia cells].
    He D; Zhang H
    Zhonghua Nei Ke Za Zhi; 2001 Oct; 40(10):654-6. PubMed ID: 11769715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abrogation of cisplatin-induced programmed cell death in human breast cancer cells by epidermal growth factor antisense RNA.
    Dixit M; Yang JL; Poirier MC; Price JO; Andrews PA; Arteaga CL
    J Natl Cancer Inst; 1997 Mar; 89(5):365-73. PubMed ID: 9060958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cisplatin-evoked DNA fragmentation in normal and cancer cells and its modulation by free radical scavengers and the tyrosine kinase inhibitor STI571.
    Wozniak K; Czechowska A; Blasiak J
    Chem Biol Interact; 2004 Apr; 147(3):309-18. PubMed ID: 15135086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fludarabine + Ara-C + G-CSF: cytotoxic effect and induction of apoptosis on fresh acute myeloid leukemia cells.
    Tosi P; Visani G; Ottaviani E; Manfori S; Zinzani PL; Tura S
    Leukemia; 1994 Dec; 8(12):2076-82. PubMed ID: 7528855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new anticancer platinum compound, (-)-(R)-2-aminomethyl-pyrrolidine(1,1-cyclobutanedicarboxylato) platinum(II): DNA interstrand crosslinking, repair and lethal effects in normal human, Fanconi's anaemia and xeroderma pigmentosum cells.
    Fujiwara Y; Nakamura M; Yokoo S
    Br J Cancer; 1993 Jun; 67(6):1285-92. PubMed ID: 8512813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topoisomerase II inhibition and altered kinetics of formation and repair of nitrosourea and cisplatin-induced DNA interstrand cross-links and cytotoxicity in human glioblastoma cells.
    Ali-Osman F; Berger MS; Rajagopal S; Spence A; Livingston RB
    Cancer Res; 1993 Dec; 53(23):5663-8. PubMed ID: 8242621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin.
    O'Neill CF; Koberle B; Masters JR; Kelland LR
    Br J Cancer; 1999 Dec; 81(8):1294-303. PubMed ID: 10604725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of nucleotide excision repair by fludarabine in normal lymphocytes in vitro, measured by the alkaline single cell gel electrophoresis (Comet) assay.
    Yamauchi T; Kawai Y; Ueda T
    Jpn J Cancer Res; 2002 May; 93(5):567-73. PubMed ID: 12036453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spiroquinazolinone-induced cytotoxicity and apoptosis in K562 human leukemia cells: alteration in expression levels of Bcl-2 and Bax.
    Ghasemian M; Mahdavi M; Zare P; Ali Hosseinpour Feizi M
    J Toxicol Sci; 2015 Feb; 40(1):115-26. PubMed ID: 25743751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased p21/WAF-1 and p53 protein levels following sequential three drug combination regimen of fludarabine, cytarabine and docetaxel induces apoptosis in human leukemia cells.
    Avramis VI; Nandy P; Kwock R; Solorzano MM; Mukherjee SK; Danenberg P; Cohen LJ
    Anticancer Res; 1998; 18(4A):2327-38. PubMed ID: 9703875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enforced expression of Bcl-XS induces differentiation and sensitizes chronic myelogenous leukemia-blast crisis K562 cells to 1-beta-D-arabinofuranosylcytosine-mediated differentiation and apoptosis.
    Ray S; Bullock G; Nuñez G; Tang C; Ibrado AM; Huang Y; Bhalla K
    Cell Growth Differ; 1996 Dec; 7(12):1617-23. PubMed ID: 8959329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imatinib increases cytotoxicity of melphalan and their combination allows an efficient killing of chronic myeloid leukemia cells.
    Giallongo C; La Cava P; Tibullo D; Parrinello N; Barbagallo I; Del Fabro V; Stagno F; Conticello C; Romano A; Chiarenza A; Palumbo GA; Di Raimondo F
    Eur J Haematol; 2011 Mar; 86(3):216-25. PubMed ID: 21198861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gemcitabine potentiates cisplatin cytotoxicity and inhibits repair of cisplatin-DNA damage in ovarian cancer cell lines.
    Moufarij MA; Phillips DR; Cullinane C
    Mol Pharmacol; 2003 Apr; 63(4):862-9. PubMed ID: 12644587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fludarabine-mediated inhibition of nucleotide excision repair induces apoptosis in quiescent human lymphocytes.
    Sandoval A; Consoli U; Plunkett W
    Clin Cancer Res; 1996 Oct; 2(10):1731-41. PubMed ID: 9816124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apoptosis induction with fludarabine on freshly isolated chronic myeloid leukemia cells.
    Zinzani PL; Buzzi M; Farabegoli P; Martinelli G; Tosi P; Zuffa E; Visani G; Testoni N; Salvucci M; Bendandi M
    Haematologica; 1994; 79(2):127-31. PubMed ID: 8063259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
    Zhang GS; Liu DS; Dai CW; Li RJ
    Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteasome inhibition leads to significant reduction of Bcr-Abl expression and subsequent induction of apoptosis in K562 human chronic myelogenous leukemia cells.
    Dou QP; McGuire TF; Peng Y; An B
    J Pharmacol Exp Ther; 1999 May; 289(2):781-90. PubMed ID: 10215653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of imatinib-resistant K562 cell line displaying resistance mechanisms.
    Hekmatshoar Y; Ozkan T; Altinok Gunes B; Bozkurt S; Karadag A; Karabay AZ; Sunguroglu A
    Cell Mol Biol (Noisy-le-grand); 2018 May; 64(6):23-30. PubMed ID: 29808796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in ceramide and sphingomyelin following fludarabine treatment of human chronic B-cell leukemia cells.
    Biswal SS; Datta K; Acquaah-Mensah GK; Kehrer JP
    Toxicology; 2000 Nov; 154(1-3):45-53. PubMed ID: 11118669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.